Potassium iodide
This article was originally published in The Tan Sheet
Executive Summary
"FDA is planning to conduct studies of the palatability, solubility and stability of KI dissolved in a number of different liquids, including juice and formula," agency says in Q&A document on use of the OTC in radiation emergencies. FDA notes it is working with KI manufacturers to "expedite submission and review" of applications for tablet dosage strengths below 130 mg and to amend "Drug Facts" labeling to incorporate new KI dosing recommendations announced in December (1"The Tan Sheet" Dec. 17, 2001, p. 5). Recommendations generally call for adults 18 and older to take 130 mg/day, children three and older 65 mg/d, children under three 32 mg/d...